GLP-1 / Semaglutide: Widely used in anti-obesity and diabetes treatments.
BPC-157: Enhances muscle and tendon recovery; supports gastrointestinal health.
Thymosin Alpha-1: Immune-enhancing peptide used as an adjunct in viral and oncological therapy.
Pharmaceutical peptides are revolutionizing modern medicine due to their high specificity, excellent safety profile, and ability to mimic natural biological pathways. Within the pharmaceutical field, peptides are widely used in metabolic regulation, tissue regeneration, immune modulation, and endocrine therapies.
One of the most representative groups is metabolic peptides, such as GLP-1 (Glucagon-Like Peptide-1) analogues, which play a vital role in regulating glucose metabolism and promoting weight loss. These peptides enhance insulin secretion, reduce appetite, and improve energy expenditure—making them essential for managing type 2 diabetes and obesity. Another key example is growth and wound healing peptides, such as BPC-157 and TB-500, known for stimulating angiogenesis, accelerating tissue repair, and reducing inflammation in both clinical and experimental settings.
GLP-1 / Semaglutide: Widely used in anti-obesity and diabetes treatments.
BPC-157: Enhances muscle and tendon recovery; supports gastrointestinal health.
Thymosin Alpha-1: Immune-enhancing peptide used as an adjunct in viral and oncological therapy.
Clinical trials have demonstrated that GLP-1 analogues can reduce HbA1c by 1.5% on average and result in significant weight loss (average 10–15% body weight reduction). BPC-157 shows consistent improvement in wound closure rates in animal models, with faster collagen synthesis and epithelial repair compared to control groups.